Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia

被引：0
|
作者：
Vanttinen, Ida [1 ,2 ]
Ruokoranta, Tanja [1 ]
Saad, Joseph J. [1 ,2 ]
Kytola, Sari [3 ]
Hellesoy, Monica [4 ]
Gullaksen, Stein-Erik [4 ]
Ettala, Pia-Sofia [5 ]
Pyorala, Marja [6 ]
Rimpilainen, Johanna [7 ]
Siitonen, Timo [8 ]
Wennerberg, Krister [9 ]
Gjertsen, Bjorn T. [4 ,10 ]
Heckman, Caroline A. [1 ,2 ]
Kontro, Mika [1 ,2 ,3 ,11 ]
Kuusanmaki, Heikki [1 ,2 ,9 ,11 ]
机构：
[1] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE, Helsinki, Finland
[2] ICAN Digital Precis Canc Med Flagship, Helsinki, Finland
[3] Helsinki Univ Hosp, Dept Hematol, Comprehens Canc Ctr, Helsinki, Finland
[4] Helse Bergen, Hematol Sect, Dept Med, Bergen, Norway
[5] Turku Univ Hosp, Dept Clin Hematol, Turku, Finland
[6] Kuopio Univ Hosp, Dept Med, Kuopio, Finland
[7] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[8] Oulu Univ Hosp, Canc Ctr, Hematol, Oulu, Finland
[9] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark
[10] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway
[11] Fdn Finnish Canc Inst, Helsinki, Finland
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189340
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prognostic Impact of Chromosomal Abnormalities in TP53-Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
    Takeda, June
    Iwasaki, Makoto
    Kanda, Junya
    Nannya, Yasuhito
    Hiramoto, Nobuhiro
    Kondo, Tadakazu
    Ishikawa, Takayuki
    Watanabe, Mitsumasa
    Kawata, Takahito
    Maeda, Takeshi
    Ueda, Yasunori
    Imada, Kazunori
    Kitano, Toshiyuki
    Tsuji, Masaaki
    Maesako, Yoshitomo
    Oka, Satoko
    Tanaka, Yasuhiro
    Miyoshi, Takashi
    Asagoe, Kosuke
    Itoh, Mitsuru
    Hirata, Hirokazu
    Kawabata, Hiroshi
    Hishizawa, Masakatsu
    Maeda, Akinori
    Yago, Kazuhiro
    Sasaki, Nana
    Uoshima, Nobuhiko
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    BLOOD, 2023, 142
  • [42] DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation
    Jang, Ji Eun
    Hwang, Doh Yu
    Eom, Ju-In
    Cheong, June-Won
    Jeung, Hoi-Kyung
    Cho, Hyunsoo
    Chung, Haerim
    Kim, Jin Seok
    Min, Yoo Hong
    CANCERS, 2023, 15 (03)
  • [43] Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia
    Pabst, Gabriel
    Prochazka, Katharina
    Pregartner, Gudrun
    Rucker, Frank G.
    Heitzer, Ellen
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Dohner, Konstanze
    Sill, Heinz
    BLOOD, 2018, 132
  • [44] Outcome of TP53-mutated CCUS and the risk of progression to myeloid neoplasms
    Shah, Syed Naseem
    Li, Marissa
    Baranwal, Anmol
    Chen, Dong
    He, Rong
    Alkhateeb, Hassan B.
    Tefferi, Ayalew
    Mangaonkar, Abhishek A.
    Al-Kali, Aref
    Patnaik, Mrinal S.
    Shah, Mithun Vinod
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
    Kim, Kunhwa
    Maiti, Abhishek
    Loghavi, Sanam
    Pourebrahim, Rasoul
    Kadia, Tapan M.
    Rausch, Caitlin R.
    Furudate, Ken
    Daver, Naval G.
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas J.
    Takahashi, Koichi
    Yilmaz, Musa
    Tang, Guilin
    Ravandi, Farhad
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    CANCER, 2021, 127 (20) : 3772 - 3781
  • [46] Outcomes of TP53-Mutant Acute Myeloid Leukemia with Venetoclax and Decitabine
    Kim, Kunhwa
    Maiti, Abhishek
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Pemmaraju, Naveen
    Borthakur, Gautam
    Bose, Prithviraj
    Issa, Ghayas C.
    Short, Nicholas J.
    Yilmaz, Musa
    Alvarado, Yesid
    Ferrajoli, Alessandra
    Jabbour, Elias
    Jain, Nitin
    Ohanian, Maro
    Takahashi, Koichi
    Thompson, Philip A.
    Rausch, Caitlin R.
    Montalbano, Kathryn
    Pierce, Sherry A.
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina
    BLOOD, 2020, 136
  • [47] Decitabine in TP53-Mutated AML
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Garcia-Manero, Guillermo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 796 - 797
  • [48] Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia
    Sariipek, Nurefsan
    Safina, Kseniia R.
    Cutler, Corey
    Ho, Vincent T.
    Koreth, John
    Lindsley, Coleman
    Luskin, Marlise R.
    Garcia, Jacqueline S.
    Hearsey, Doreen
    Lu, Wesley S.
    Li, Shuqiang
    Livak, Kenneth J.
    Griffin, Gabriel K.
    Soiffer, Robert J.
    Ritz, Jerome
    Wu, Catherine J.
    Antin, Joseph H.
    Lane, Andrew A.
    Van Galen, Peter
    Gooptu, Mahasweta
    BLOOD, 2023, 142
  • [49] p53 immunohistochemistry as an ancillary tool for rapid assessment of residual disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes
    Brar, Nivaz
    Lawrence, Lauren
    Fung, Eula
    Zehnder, James L.
    Greenberg, Peter L.
    Mannis, Gabriel N.
    Zhang, Tian Y.
    Gratzinger, Dita
    Oak, Jean
    Silva, Oscar
    Kurzer, Jason
    Tan, Brent
    Menke, Joshua R.
    Fernandez-Pol, Sebastian
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 (03) : 269 - 281
  • [50] Treatment outcomes for newly diagnosed, untreated TP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.
    Daver, Naval Guastad
    Iqbal, Shahed
    Renard, Camille
    Chan, Rebecca J.
    Hasegawa, Ken
    Hu, Hao
    Tse, Preston
    Yan, Jiajun
    Zoratti, Michael J.
    Xie, Feng
    Ramsingh, Giridharan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19020 - E19020
12345